Correlation of differential ascites volume with primary cytoreductive surgery outcome, lymph node involvement, and disease recurrence in advanced ovarian cancer

The prognostic value of perioperative, pre-systemic therapy CA125 levels in patients with high-grade serous ovarian cancer

(2017) Taymaa May et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer

(2016) Xia Xu et al.   Journal of Ovarian Research

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

(2015) James S. Ferriss et al.   GYNECOLOGIC ONCOLOGY

Impact of Prognostic Factors on Survival Rates in Patients with Ovarian Carcinoma

(2014) Sevim Kalsen Arikan et al.   Asian Pacific Journal of Cancer Prevention

A survival analysis comparing women with ovarian low-grade serous carcinoma to those with high-grade histology

(2014) Ming Chen et al.   OncoTargets and Therapy

Molecular Profiling and Clinical Outcome of High-Grade Serous Ovarian Cancer Presenting with Low- versus High-Volume Ascites

(2014) Tomer Feigenberg et al.   Biomed Research International

Timing and Pattern of Recurrence in Ovarian Cancer Patients with High Tumor Dissemination Treated with Primary Debulking Surgery Versus Neoadjuvant Chemotherapy

(2013) M. Petrillo et al.   ANNALS OF SURGICAL ONCOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS